# Akari Therapeutics Plc: insider transactions

AKTX · Nasdaq · CIK 1541157 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aktx.md) · [Financials](/companies/aktx/financials.md) · [Filings](/companies/aktx/filings.md) · [Insiders](/companies/aktx/insiders.md)

## All transactions: 0

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

No insider transactions of this kind are in coverage.

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 17:09 ET. No prices; not investment advice.
